We describe a method that enables detection and immunophenotypical characterization of distinct subpopulations within a cytogenetically defiied tumor clone. CoariSting normal cells do not hinder microscopic evaluation because they can be distinguished from cytogenetically aberrant tumor cells. This is also true when normal and neoplastic cells cannot be dearly distinguished by cytology or immunohistochemistry, i.e., if both constituents have similar immunophenotypes and morphology. The method is based on fluorescence double staining for two Werent antigens com-
Introduction
Recently we introduced a method for simultaneous fluorescence immunophenotyping and interphase cytogenetics that unequivocally assigns cytogenetically determined aneuploid tumor cells to a certain cell lineage (Weber-Matthiesen et al., 1993a; Weber-Matthiesen et al., 1992) . The technique is based on fluorescence immunophenotyping combined with in situ hybridization with a single or cocktails of centromere-specific DNA probes (interphase cytogenetics). In this way clonal tumor cells are identified by numerical chromosome aberrations. The method is referred to as "Fluorescence immunophenotyping and Interphase Cytogenetics as a Tool for Investigation of Neoplasms (FICTION) ." Being accessible to fluorescence microscopy, FICTION can be employed in large series of studies due to both staining within a single day and rapid evaluation within minutes. In addition, cryostat sections can be processed by the FICTION method (Weber-Matthiesen et al., 1993b) .
Supported by grants from the Deutsche Krebshilfe (W10/92/Schll) and Schleswig-Holsteinkche Krebsgesellschaft. JD was supported by the Friedrich Naumann Stiftung. If a given antigen is expressed by tumor cells and also by accompanying normal cells, positive normal and malignant cells can be distinguished by FICTION. However, characterizing the cell lineage of positive normal cells was not possible with FICTION in its previously described form. Combining interphase cytogenetics and immunophenotyping with only a single monoclonal antibody is not sufficient to obtain detailed immunophenotypical data about tumor cells and coexisting normal cells in such cases. Therefore, we have extended our method to three-color analysis by employing fluorescence double staining for two different antigens combined with fluorescence interphase cytogenetic analysis. In a case of follicular lymphoma we demonstrate that FICTION can distinguish six immunophenotypically and cytogenetically defined cell types on a single cytospin. We show in the present case that a few normal T-cells among the majority of cytogenetically defined tumor cells are also bcl-2-positive. (6, blue) and hybridized with achromosome 12 centromeric probe (A, green). Because hybridization signals are located in different focusing levels in the large polylobulated cells, only some hybridization signals can be documented on a single photograph. Assigning signals to individual nuclei is no problem during microscopic evaluation. Arrowhead points to a bcl-2 positive trisomic cell. Signal assignment was done by simultaneous phase-contrast analysis. All three signals are split into discrete chromatid signals. Arrows point to one bcl-'2-positive (small arrow) and two bcl-2-negative (large arrows) cells which proved io be disomic (normal) during microscopic analysis (A). All arrowed cells are CD3-positive T-cells (B).
Materials and Methods

Cells
Original magnification x 1200. Bar = 5 bm.
Probes.
A centromeric DNA probe specific for chromosome 12 (Dl2Zl) (American Type Culture Collection; Rockville, MD) was FIX-labeled by random primed labeling using an ECL labeling kit (Amersham-Buchler; Braunschweig, Germany), according to the manufacturer's instructions.
Immunophenotyping of Cytospins. Slides were fixed in acetone at room temperature (RT) for 10 min and incubated with the monoclonal antibodies (MAb) anti-bcl-2 (tumor specimens) and L26lCD20 (control specimens). MAb were from Dakopatts (Hamburg, Germany). Unrelated antibodies were used to rule out unspecific binding to tissue components of secondary antibodies. MAbs were visualized by incubation with Cy3-conjugated rabbit anti-mouse followed by Cy3-conjugated donkey anti-rabbit polydonal antibodies UacksonlDianova: Hamburg, Germany).
Detection of the second antigen was initiated by pre-incubation with 20% normal mouse serum to block any vacant binding sites of the rabbit anti-mouse antibody employed in the first antibody cascade. Biotinylated MAb Leu4lCD3 diluted 1:50 in 20% normal mouse serum was added to the mouse serum without preceding washes. The biotinylated antibody was visualized with AMCA-conjugated avidin (Vector: Burlingame, CA). Enhancement of fluorescence intensity was performed with biotinylated goat anti-avidin (Vector), followed by AMCA-conjugated avidin. Further amplification was possible by repeating the last two incubation steps. All incubations were performed at RT for 30 min. They were followed by three 2-min washes in phosphate buffer (0.1 M NaH2P04, 0.1 M Na2HP04, pH 8). Polyclonal antibodies and AMCA-conjugated avidin were diluted 1:200 in PNM buffer (5 % non-fat dry milk, 0.02 % Na azide in phosphate buffer).
In Situ Hybridization. After immunophenotyping slides were fixed in ice-cold Carnoy's fmtive (methanolacetic acid, 3:l) for 10 min, briefly washed in distilled water, fiied in 1% paraformaldehyde (2 x SSC, pH 7.6) for 10 min, briefly washed in distilled water, and dehydrated in 70, 80, and 100% ethanol. Double-stained slides were hybridized with an FIX-labeled centromeric probe specific for chromosome 12, as follows: 1 pJ hybridization mixture (1 ng FITC-conjugated probe, 50 ng sonicated salmon sperm DNA, 10% dextran sulfate, 60% formamide, 1 x SSC) was placed on the cell-containing area of each slide and covered with a 10-mm round coverslip. After sealing with rubber cement, slides were denatured at 76'C for 5 min and incubated at 37°C for 1 hr. After hybridization slides were washed three times in 50% formamide, 2 x SSC at 45'C. followed by briefequilibration in phosphate buffer at RT. HE-conjugated probes were detected with monoclonal mouse anti-FIX (Dakopatts), followed by FIX-conjugated horse anti-mouse (Vector). Amplification was performed by repeating both detection steps. Antibodies were diluted 1:200 in PNM. All incubations were followed by three 2 min washes in phosphate buffer. Slides were covered with anti-fade medium containing p-phenylenediamine (Sigma; Deisenhofen, Germany) in glycerol.
Checking the quality of in situ hybridization is carried out in regular intervals in our laboratory. Sensitivity and specificity of interphase cytogenetic analysis were in accordance with data previously reported by us and others (Weber-Matthiesen et al., 1992, and references cited therein) .
Results
Normal and malignant cells were differentiated by disomic and trisomic numbers of chromosome 12. Six immunophenotypically distinct cell types could be distinguished (Table 1) .
Tumor cells consisted of two types, CD3-negative/bcl-2-negatlve trisomic cells as well as CD3-negativeI bcl-2-positive trisomic (10% of all trisomic cells). A remarkable morphological heterogeneity was observed among tumor cells, comprising cells with polylobulated nuclei, large cells with round or oval nuclei, and small cells with little cytoplasm (Figure 1 ). Fluorescence intensities of bcl-2positive cells were variable. There was no correlation between fluorescence intensity and morphological appearance.
Among normal cells, defined by presence of two hybridization signals, we could discriminate CD3-negative/ bcl-2 positive disomic cells (possibly memory B-cells, plasma cells), CD3-negativelbcl-2negative disomic cells (e.g., normal B-cells, monocytes, mast cells), CD3-positive/bcl-2-negative disomic cells (T-cells), and CD3-positivel bcl-2-positive disomic cells (Figure 1) . The latter comprised about 3% of T-cells.
Strong fluorescence intensities of both AMCA-and CY3-labeled cells provided rapid and unequivocal evaluation of immunophenotypes. Brief exposure times, e.g., 1-5 sec with a 400 ASA film contributed to the quality of photographs.
Immunophenotypic and interphase cytogenetic analysis was performed simultaneously by fluorescence microscopy. High cell densities on cytospin preparations sometimes complicated the precise assignment of hybridization signals to individual cells. In these cases definite assignment was achieved by simultaneous phase-contrast analysis.
Control Experiments
Double immunophenotyping with L26/CD20 (B-cell) and L e d / CD3 (T-cell) was performed to exclude crossreactivity of reagents used in the two cascades. Double-positive cells were never observed, whereas single-positive Tand B-cells were strongly stained.
Discussion
FICTION was originally planned to assign tumor cells to a cytogenetically defined clone and, at the same time, to determine the cell lineage of every individual cell (Weber-Matthiesen et al., 1992) . In most cases a single MAb is sufficient to study the cell lineage, e.g., CD3 for T-cells or CD19 for B-cells. However, more immunophenotypical details are required if tumor cells are immunophenotypically heterogeneous or, as in the present case, tumorassociated antigens are also expressed by some normal cells. Tumor cells of the present case typically had the translocation t(14;18) (q32.3;q21), which causes overexpression of bcl-2 proteins due to chromosomal rearrangement of immunoglobulin and bcl-2 genes (Vaux et al., 1988; 'hjimoto et al., 1985) . Some normal cells, e.g., memory B-cells and very few T-cells, may also express bcl-2 (Hockenbery et al., 1991; . Detecting bcl-2 positivity of these non-malignant constituents and, at the same time, determining their cell lineage is possible with the modified FICTION method. We demonstrate here that FIC-TION with double immunophenotyping can differentiate bcl-2 positive malignant and non-malignant cells and moreover can verdy the presence of bcl-2-positive T-lymphocytes belonging to the cytogenetically normal compartment. In all, we could easily discriminate six different subpopulations according to immunophenotypical and cytogenetical features.
The major problem in double immunophenotyping is caused by the fact that most MAb are raised in the same animal species, i.e., in mouse. Enhancement of fluorescence intensity is difficult because the different constituents used to build the two fluorescence cascades must not crossreact with each other. This problem is usually circumvented by staining one ofthe antigens with a directly labeled MAb without further amplification. Unfortunately, fluorescence intensity often is not sufficient for fluorescence microscopy in this direct procedure. If primary antibodies differ in subtype (e.g., IgM, IgG2a, IgG2b, kappa, lambda), subtype-specific secondary antibodies are useful. However, in many cases primary antibodies with different subtypes are not available. In our system the first MAb is visualized by the usual three-step fluorescence procedure. The second (biotinylated) MAb is detected indirectly by a technique commonly used for visualization of biotinylated DNA probes (Pinkel et al.; 1986) . Consisting of only two components, thereby enabling repeated amplification cycles, it is particularly suitable in double staining. Crossreactivities between the two de-tection systems were never observed in our control experiments.
FICTION is applicable in routine diagnostics because it is easily performed and evaluated during a single day. Rapid evaluation provides its applicability in studies with great numbers of cases.
FICTION is as yet restricted to tumor clones with aneuploid chromosome numbers. Unfortunately, many tumor cells have structural rather than numerical chromosome aberrations. Therefore, we are currently working out fluorescence procedures that enable detection of structural aberrations in immunophenotyped cells using Ah-PCR-generated YAC probes (Lengauer et al., 1992) . We are optimistic that modifications of FICTION will soon be capable of immunophenotyping tumor cells with distinct structural chromosome aberrations such as t( 1418) in follicular lymphoma, t( 8;14) in Burkitt lymphoma, and t(9;22) in Ph-positive chronic myeloid leukemia.
